Pharmaceutical companies and their patent expiries

Dieser Artikel steht derzeit nicht zur Verfügung!

49,00 € *

inkl. MwSt. zzgl. Versandkosten

Derzeit nicht lieferbar.

Verlag: LAP Lambert Academic Publishing
Autor: Henriette van Looveren
Artikel-Nr.: KNV34376713
ISBN: 9783659209598

Pharmaceutical companies face difficult times when a patent of a brand name drug expires. Brand... mehr

Menü schließen

Produktinformationen "Pharmaceutical companies and their patent expiries"

Pharmaceutical companies face difficult times when a patent of a brand name drug expires. Brand name drugs often see a large decline in their sales value. This research studies, using five case studies, what pharmaceutical companies do to overcome such a sales decline. The used strategies are evaluated, using sales values, to see whether these strategies work. Pharmaceutical companies have five possible brand extension strategies they can use, namely: Extended release (XR), new indication, second generation, fixed-dose-combination (FDC) and over-the-counter (OTC). Based on the results of this research, the second generation strategy is the most effective strategy pharmaceutical companies can use to overcome patent expiry of their blockbuster brand name drugs.

Weiterführende Links zu "Pharmaceutical companies and their patent expiries"

Bewertungen lesen, schreiben und diskutieren... mehr

Menü schließen

Kundenbewertungen für "Pharmaceutical companies and their patent expiries"

Bewertung schreiben

Bewertungen werden nach Überprüfung freigeschaltet.